INTERACTIONS OF THE DYE EVANS-BLUE AND GYKI-52466, A 2,3-BENZODIAZEPINE, WITH LPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTORS IN CULTURED RAT CORTICAL-NEURONS - ELECTROPHYSIOLOGICAL EVIDENCE FOR AT LEAST 2 DIFFERENT BINDING-SITES FOR NONCOMPETITIVE ANTAGONISTS
T. Weiser et al., INTERACTIONS OF THE DYE EVANS-BLUE AND GYKI-52466, A 2,3-BENZODIAZEPINE, WITH LPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTORS IN CULTURED RAT CORTICAL-NEURONS - ELECTROPHYSIOLOGICAL EVIDENCE FOR AT LEAST 2 DIFFERENT BINDING-SITES FOR NONCOMPETITIVE ANTAGONISTS, Neuroscience letters, 216(1), 1996, pp. 29-32
The effects of the dye Evans Blue and GYKI 52466, a 2,3-benzodiazepine
, on lpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/ka
inate receptors in primary cultured rat cortical neurons were investig
ated using the patch-clamp technique. Evans Blue and GYKI 52466 reduce
d the currents induced by the application of 100 mu M kainate with IC5
0 values of 10.6 +/- 1.4 mu M and 12.1 +/- 0.4 mu M, respectively. In
contrast to the similar potencies of the two compounds, their kinetics
of block were quite different with those of Evans Blue being more com
plex. The on-, as well as the off-reaction of the block by GYKI 52466
could be described by single exponential functions, whereas two differ
ent time-constants for binding and one time-constant for the unbinding
of Evans Blue were found. The block of AMPA receptors by Evans Blue w
as not completely reversible under the experimental conditions applied
in this study. GYKI 52466 was not able to augment the recovery after
inhibiting AMPA receptors with Evans Blue. Moreover, preapplication of
a high concentration of GYKI 52466 did not prevent the inhibition of
AMPA receptors by Evans Blue. We therefore conclude that GYKI 52466 an
d Evans Blue bind to two different sites at AMPA receptors in primary
cultured cortical neurons.